MOHAMMED INAYATHULLAH;RAJADAS, JAYAKUMAR;NAZIR AHMED, MOHAMMED INAYATHULLAH;POTHINENI, VENKATA RAVEENDRA;NAZIR AHMED
发明人:
NAZIR AHMED, MOHAMMED INAYATHULLAH,RAJADAS, JAYAKUMAR,POTHINENI, VENKATA RAVEENDRA
申请号：
CA3011903
公开号：
CA3011903A1
申请日:
2017.01.17
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Disclosed herein are methods and drug compositions for treating Lyme disease and post- treatment Lyme disease syndrome (PTLDS) or chronic Lyme disease (CLD). In one embodiment, a method of treating a subject with Lyme disease involves administering an effective amount of a therapeutic agent selected from the group consisting of tetraethylthiuram disulfide, doxorubicin, epirubicin, azlocillin, cephalothin, josamycin, cefotaxime, cefazolin, erythromycin, calcimycin, gramicidin, cefdinir, gambogic acid, ceftazidime, ticarcillin, valinomycin, moxifloxacin, linezolid, idarubicin, tosufloxacin, loratadine, ceftriaxone, and combinations thereof, and pharmaceutical salts, hydrates, and solvates thereof.
